Acrivon Therapeutics, Inc.'s total assets for Q2 2024 were $230.59M, an increase of 91.32% from the previous quarter. ACRV total liabilities were $14.53M for the fiscal quarter, a 15.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.